ACCENT MICROCELL LTD. has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 1,973 | 2,455 | 24.4% |
Other income | Rs m | 25 | 36 | 45.8% |
Total Revenues | Rs m | 1,998 | 2,491 | 24.7% |
Gross profit | Rs m | 190 | 385 | 103.0% |
Depreciation | Rs m | 41 | 44 | 7.8% |
Interest | Rs m | 25 | 11 | -54.8% |
Profit before tax | Rs m | 148 | 365 | 146.8% |
Tax | Rs m | 26 | 64 | 147.7% |
Profit after tax | Rs m | 122 | 302 | 146.6% |
Gross profit margin | % | 9.6 | 15.7 | |
Effective tax rate | % | 17.3 | 17.4 | |
Net profit margin | % | 6.2 | 12.3 |
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Networth | Rs m | 504 | 1,638 | 224.9 |
Current Liabilities | Rs m | 562 | 465 | -17.3 |
Long-term Debt | Rs m | 55 | 15 | -72.6 |
Total Liabilities | Rs m | 1,132 | 2,135 | 88.5 |
Current assets | Rs m | 802 | 1,721 | 114.7 |
Fixed Assets | Rs m | 330 | 414 | 25.4 |
Total Assets | Rs m | 1,132 | 2,135 | 88.5 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-23 | Mar-24 | ||
Cash Flow from Operating Activities | Rs m | 76 | 113 | 49.6% |
Cash Flow from Investing Activities | Rs m | -40 | -823 | - |
Cash Flow from Financing Activities | Rs m | -43 | 723 | - |
Net Cash Flow | Rs m | -8 | 13 | - |
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 152.5 | 116.7 |
TTM Earnings per share | Rs | 9.5 | 14.3 |
Diluted earnings per share | Rs | 5.8 | 14.3 |
Price to Cash Flow | x | 0.0 | 17.9 |
TTM P/E ratio | x | 0.0 | 18.4 |
Price / Book Value ratio | x | 0.0 | 3.8 |
Market Cap | Rs m | 0 | 6,187 |
Dividends per share (Unadj.) | Rs | 0.8 | 1.0 |
Current Ratio: The company's current ratio improved and stood at 3.7x during FY24, from 1.4x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 32.9x during FY24, from 6.8x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company declined and down at 18.4% during FY24, from 24.3% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company declined and down at 22.8% during FY24, from 31.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company improved and stood at 14.7% during FY24, from 13.0% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Current ratio | x | 1.4 | 3.7 |
Debtors’ Days | Days | 562 | 800 |
Interest coverage | x | 6.8 | 32.9 |
Debt to equity ratio | x | 0.1 | 0.0 |
Return on assets | % | 13.0 | 14.7 |
Return on equity | % | 24.3 | 18.4 |
Return on capital employed | % | 31.0 | 22.8 |
To see how ACCENT MICROCELL LTD. has performed over the last 5 years, please visit here.
Over the last one year, ACCENT MICROCELL LTD. share price has moved down from Rs 0.0 to Rs 0.0, registering a loss of Rs 0.0 or around 0.0%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 41,058.7 (up 0.7%). Over the last one year it has moved up from 28,042.9 to 41,058.7, a gain of 13,016 points (up 46.4%).
Overall, the NIFTY 50 is up 0.8% over the year.
(To know more, check out historical annual results for ACCENT MICROCELL LTD. and quarterly results for ACCENT MICROCELL LTD.)
ACCENT MICROCELL LTD. currently trades at Rs 238.5 per share. You can check out the latest share price performance of ACCENT MICROCELL LTD. here...
The revenues of ACCENT MICROCELL LTD. stood at Rs 2,491 m in FY24, which was up 24.7% compared to Rs 1,998 m reported in FY23.
ACCENT MICROCELL LTD.'s revenue has grown from Rs 1,348 m in FY21 to Rs 2,491 m in FY24.
Over the past 4 years, the revenue of ACCENT MICROCELL LTD. has grown at a CAGR of 22.7%.
The net profit of ACCENT MICROCELL LTD. stood at Rs 302 m in FY24, which was up 146.6% compared to Rs 122 m reported in FY23.
This compares to a net profit of Rs 59 m in FY22 and a net profit of Rs 48 m in FY21.
Over the past 4 years, ACCENT MICROCELL LTD. net profit has grown at a CAGR of 84.5%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of ACCENT MICROCELL LTD. reveals:
Here's the cash flow statement of ACCENT MICROCELL LTD. for the past 4 years.
(Rs m) | FY21 | FY22 | FY23 | FY24 |
---|---|---|---|---|
From Operations | 50 | 149 | 76 | 113 |
From Investments | -63 | -43 | -40 | -823 |
From Financial Activity | -22 | -97 | -43 | 723 |
Net Cashflow | -34 | 9 | -8 | 13 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of ACCENT MICROCELL LTD. reveals:
Here's the ratio/financial analysis of ACCENT MICROCELL LTD. for the past 4 years.
FY21 | FY22 | FY23 | FY24 | |
---|---|---|---|---|
Operating Profit Margin (%) | 8.1 | 7.8 | 9.6 | 15.7 |
Net Profit Margin (%) | 3.6 | 3.6 | 6.2 | 12.3 |
Debt to Equity Ratio (x) | 0.7 | 0.2 | 0.1 | 0.0 |
Equitymaster requests your view! Post a comment on "ACCENT MICROCELL LTD. 2023-24 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!